An Innovative Job Placement Model for Unemployed Methadone Patients: A Randomized Clinical Trial
Institute for Treatment and Services Research at National Development and Research Institutes, New York, NY 10010, USA. Substance Use & Misuse
(Impact Factor: 1.23).
02/2007; 42(5):811-28. DOI: 10.1080/10826080701202403
This article presents the outcomes of an innovative vocational rehabilitation model designed for methadone-maintained patients -- the Customized Employment Supports (CES) model. CES counselors work intensively with a small caseload of patients to overcome the vocational as well as non-vocational barriers that hinder employment, with the goal of attaining rapid job placement. A randomized clinical trial was implemented at two methadone treatment programs in New York City and was funded by the National Institute on Drug Abuse The study tested the hypothesis that patients assigned to the experimental (CES) condition would have better employment outcomes than those assigned to a control condition who received standard vocational counseling at the programs. The data were collected from May 2001 through April 2005. The efficacy sample for the analysis consisted of 168 patients who completed follow-up interviews. The sample was 58% male, 75% minority group, average age 45 years, and in methadone treatment for an average of five years. The results supported the hypothesis for two measures of employment; i.e., the CES group was significantly more likely than the control group to obtain both any paid employment and informal paid employment. However, there were no significant differences for competitive employment or total earnings. The study's limitations are noted. Implications of the findings for the improvement of vocational rehabilitation for addiction patients are discussed.
Available from: Laura Blankertz
- "Eligibility: The CES model is designed primarily for methadone patients who are unemployed but want to work. Patients who used illicit opioids or cocaine in the past 30 days, or who had a serious mental illness that was not stabilized, were not eligible in the original implementation of CES due to the insurmountable barriers this might present (Magura et al., 2007). Patients had to demonstrate four consecutive weekly urines negative for cocaine and opioids before becoming eligible for CES. "
Available from: Linda Bauld
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.